A randomized study of interferon alpha-2b versus no treatment as consolidation after high dose therapy and autologous stem cell transplantation for patients with relapsed lymphoma.
Phase of Trial: Phase II
Latest Information Update: 11 Dec 2015
At a glance
- Drugs Interferon alpha-2b (Primary)
- Indications Lymphoma
- Focus Therapeutic Use
- 11 Dec 2015 New trial record